Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Gruber

Showing results (171-180 of 355) with videos related to

Pageof 36
Sort By:
Vaccine|October 3, 2009
Efficacy and safety of a live attenuated influenza vaccine in adults 60 years of age and olderPierre J T De Villiers, A Duncan Steele, Louis A Hiemstra, et al.
Revista Panamericana De Salud Publica = Pan American Journal of Public Health|August 14, 2013
Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in MexicoMaricruz Gutiérrez Brito, Allison Thompson, Douglas Girgenti, et al.
Glia|April 29, 2015
The control of reactive oxygen species production by SHP-1 in oligodendrocytesRoss C Gruber, Daria LaRocca, Scott B Minchenberg, et al.
Human Vaccines & Immunotherapeutics|July 16, 2015
Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine compared to the 23-valent pneumococcal polysaccharide vaccine in elderly Japanese adultsMasanari Shiramoto, Ryuzo Hanada, Christine Juergens, et al.
Vaccine|September 10, 2019
Phase 1 trial of a 20-valent pneumococcal conjugate vaccine in healthy adultsAllison Thompson, Erik Lamberth, Joseph Severs, et al.
Journal of Clinical Microbiology|May 4, 2007
Comparison of results of detection of rhinovirus by PCR and viral culture in human nasal wash specimens from subjects with and without clinical symptoms of respiratory illnessPeter F Wright, Anne M Deatly, Ruth A Karron, et al.
Vaccines|January 8, 2025
A Statistical Model to Predict Protection Against Infant Respiratory Syncytial Virus Disease Through Maternal ImmunizationBing Cai, Yili Chen, Yasmeen Agosti, et al.
Cell Reports|August 2, 2018
Autophagy Is a Tolerance-Avoidance Mechanism that Modulates TCR-Mediated Signaling and Cell Metabolism to Prevent Induction of T Cell AnergyEnric Mocholi, Samuel D Dowling, Yair Botbol, et al.
Clinical and Vaccine Immunology : CVI|July 4, 2014
Post hoc analysis of a randomized double-blind trial of the correlation of functional and binding antibody responses elicited by 13-valent and 7-valent pneumococcal conjugate vaccines and association with nasopharyngeal colonizationChristine Juergens, Scott Patterson, James Trammel, et al.
The Journal of Infectious Diseases|October 31, 2014
Efficacy of 13-valent pneumococcal conjugate vaccine (PCV13) versus that of 7-valent PCV (PCV7) against nasopharyngeal colonization of antibiotic-nonsusceptible Streptococcus pneumoniaeRon Dagan, Christine Juergens, James Trammel, et al.
Pageof 36

Showing results (171-180 of 355) with videos related to

Sort By:
Pageof 36
Vaccine|October 3, 2009
Efficacy and safety of a live attenuated influenza vaccine in adults 60 years of age and olderPierre J T De Villiers, A Duncan Steele, Louis A Hiemstra, et al.
Revista Panamericana De Salud Publica = Pan American Journal of Public Health|August 14, 2013
Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in MexicoMaricruz Gutiérrez Brito, Allison Thompson, Douglas Girgenti, et al.
Glia|April 29, 2015
The control of reactive oxygen species production by SHP-1 in oligodendrocytesRoss C Gruber, Daria LaRocca, Scott B Minchenberg, et al.
Human Vaccines & Immunotherapeutics|July 16, 2015
Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine compared to the 23-valent pneumococcal polysaccharide vaccine in elderly Japanese adultsMasanari Shiramoto, Ryuzo Hanada, Christine Juergens, et al.
Vaccine|September 10, 2019
Phase 1 trial of a 20-valent pneumococcal conjugate vaccine in healthy adultsAllison Thompson, Erik Lamberth, Joseph Severs, et al.
Journal of Clinical Microbiology|May 4, 2007
Comparison of results of detection of rhinovirus by PCR and viral culture in human nasal wash specimens from subjects with and without clinical symptoms of respiratory illnessPeter F Wright, Anne M Deatly, Ruth A Karron, et al.
Vaccines|January 8, 2025
A Statistical Model to Predict Protection Against Infant Respiratory Syncytial Virus Disease Through Maternal ImmunizationBing Cai, Yili Chen, Yasmeen Agosti, et al.
Cell Reports|August 2, 2018
Autophagy Is a Tolerance-Avoidance Mechanism that Modulates TCR-Mediated Signaling and Cell Metabolism to Prevent Induction of T Cell AnergyEnric Mocholi, Samuel D Dowling, Yair Botbol, et al.
Clinical and Vaccine Immunology : CVI|July 4, 2014
Post hoc analysis of a randomized double-blind trial of the correlation of functional and binding antibody responses elicited by 13-valent and 7-valent pneumococcal conjugate vaccines and association with nasopharyngeal colonizationChristine Juergens, Scott Patterson, James Trammel, et al.
The Journal of Infectious Diseases|October 31, 2014
Efficacy of 13-valent pneumococcal conjugate vaccine (PCV13) versus that of 7-valent PCV (PCV7) against nasopharyngeal colonization of antibiotic-nonsusceptible Streptococcus pneumoniaeRon Dagan, Christine Juergens, James Trammel, et al.
Pageof 36